In situ eosinophil activation in 26 primary cutaneous T-cell lymphomas with blood eosinophilia
Open Access
- 31 January 2005
- journal article
- Published by Elsevier in Journal of the American Academy of Dermatology
- Vol. 52 (1) , 32-39
- https://doi.org/10.1016/j.jaad.2004.03.003
Abstract
No abstract availableKeywords
This publication has 54 references indexed in Scilit:
- Increased interleukin 5 production in eosinophilic S?zary syndrome: Regulation by interferon alfa and interleukin 12Journal of the American Academy of Dermatology, 2001
- Abnormal Clones of T Cells Producing Interleukin-5 in Idiopathic EosinophiliaNew England Journal of Medicine, 1999
- Chronic eosinophilic pneumonia associated with cutaneous T-cell lymphomaAmerican Journal of Hematology, 1999
- Lyn, Jak2, and Raf-1 Kinases Are Critical for the Antiapoptotic Effect of Interleukin 5, whereas only Raf-1 Kinase Is Essential for Eosinophil Activation and DegranulationThe Journal of Experimental Medicine, 1998
- Increased interleukin‐6 production during the acute phase of the syndrome of episodic angioedema and hypereosinophiliaClinical and Experimental Allergy, 1998
- Predominant TH2-like Bronchoalveolar T-Lymphocyte Population in Atopic AsthmaNew England Journal of Medicine, 1992
- GM-CSF, IL-3 and IL-5: cross-competition on human haemopoietic cellsImmunology Today, 1992
- A current perspective on the role of eosinophils in dermatologic diseasesJournal of the American Academy of Dermatology, 1991
- Acute Lymphoblastic Leukemia with EosinophiliaMedicine, 1990
- Selective peripheral blood eosinophilia associated with survival advantage in Hodgkin's disease (BNLI Report No 31). British National Lymphoma Investigation.Journal of Clinical Pathology, 1987